BioCentury
ARTICLE | Company News

EUSA, Opi deal

March 5, 2007 8:00 AM UTC

EUSA acquired OPi for more than E100 million ($131.7 million). The exact sum was not disclosed. OPi markets Erwinase crisantaspase and Kidrolase L-asparaginase, both for acute lymphoblastic leukemia...